Fredun Pharmaceuticals Ltd Q1 FY2025 PAT slips QoQ to Rs. 4.12 crore

Fredun Pharmaceuticals Ltd has reported Standalone financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 78.8108 crores during the period ended June 30, 2024 as compared to Rs. 118.0330 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 4.1299 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 5.0624 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 8.79 for the period ended June 30, 2024 as compared to Rs. 10.77 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 78.8108 crs	₹118.0330 crs	-33.23%
Net Profit	₹4.1299 crs	₹5.0624 crs	-18.42%
EPS	₹8.79	₹10.77	-18.38%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 78.8108 crores during the period ended June 30, 2024 as compared to Rs.62.0455 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.4.1299 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.2.4017 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.8.79 for the period ended June 30, 2024 as compared to Rs.5.24 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 78.8108 crs	₹62.0455 crs	27.02%
Net Profit	₹4.1299 crs	₹2.4017 crs	71.96%
EPS	₹8.79	₹5.24	67.75%

Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 874.90 as compared to the previous close of Rs. 861.05. The total number of shares traded during the day was 12774 in over 388 trades.

The stock hit an intraday high of Rs. 892.00 and intraday low of 850.00. The net turnover during the day was Rs. 11246070.00.

Source : Equity Bulls

Keywords

FredunPharmaceuticals Q1FY25 FY2025 Q1FY2025 ResultUpdate